S&P Futures
4,232.00 +22.25 (+0.53%) Dow Futures
33,463.00 +159.00 (+0.48%) Nasdaq Futures
13,387.00 +75.75 (+0.57%) Russell 2000 Futures
1,989.00 +12.70 (+0.64%) Crude Oil
94.24 -0.10 (-0.11%) Gold
1,801.50 -5.70 (-0.32%)
Mastercard Incorporated (MA)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 353.38 |
| Open | 355.85 |
| Bid | 330.00 x 1800 |
| Ask | 0.00 x 900 |
| Day's Range | 350.35 - 355.85 |
| 52 Week Range | 303.65 - 399.92 |
| Volume | |
| Avg. Volume | 2,881,262 |
| Market Cap | 344.465B |
| Beta (5Y Monthly) | 1.03 |
| PE Ratio (TTM) | 43.12 |
| EPS (TTM) | 8.13 |
| Earnings Date | Apr 27, 2022 - May 02, 2022 |
| Forward Dividend & Yield | 1.96 (0.55%) |
| Ex-Dividend Date | Jul 07, 2022 |
| 1y Target Est | 419.62 |
- Zacks
5 Stocks With High ROE to Buy on Downtrend in Inflation Data
Marriott (MAR), Mastercard (MA), Builders FirstSource (BLDR), Rockwell (ROK) and ON Semiconductor (ON) are some of the stocks with high ROE to profit as inflation shows signs of cooling.
- Yahoo Finance Video
Credit card customers should be 'mindful of ongoing earn' benefits: Analyst
Krista Phillips, Wells Fargo Credit Cards Head of Branded Cards and Marketing, explains which credit card rewards consumers should be more aware of, ranging from travel expenditures to points for paying for food.
- Motley Fool
Paysign (PAYS) Q2 2022 Earnings Call Transcript
This call may include comments that may be deemed to be forward-looking statements under the federal securities laws and the company intends that such forward-looking statements be subject to the safe harbor created thereby. All statements other than statements of fact included on this call are forward-looking statements. Such forward-looking statements include, among others, that our unrestricted cash, anticipated revenues and profits will be sufficient to sustain operations for the next 12 months; that the expected total revenue, gross profit margin, operating expenses, depreciation and amortization, stock-based compensation, adjusted EBITDA, plasma revenues, new plasma center additions, pharma revenues and new pharma co-pay customer additions for 2022 meet our expectations; that the company will continue to post year-over-year improvements; that the company's growth prospects in plasma, pharma and other prepaid business materialize; and that the company will continue to be affected by COVID-19-related labor shortages.
